AI Article Synopsis

  • The study involved 168 patients with advanced or recurrent breast cancer who received hyperthermia or immunotherapy after standard treatments failed or were declined.
  • Clinical benefits were seen in 26 patients, with complete responses occurring in 4 cases.
  • The combination of hyperthermia with immunotherapy significantly improved effectiveness, especially in 20 patients with distant metastases to solid organs.

Article Abstract

We treated 168 advanced or recurrent breast cancer patients with hyperthermia or immunotherapy (2005/7-2011/12). In these cases, standard therapy showed no effect or was refused. Clinical benefit( complete response: CR, partial response, and long stable disease) was observed in 26 cases; CR occurred in 4 cases. The effective rate of immunotherapy increased from 9.1% to 23.9% using hyperthermia. Both hyperthermia and immunotherapy needed to be used together to be effective in 20 cases with distant metastases to solid organs.

Download full-text PDF

Source

Publication Analysis

Top Keywords

advanced recurrent
8
recurrent breast
8
breast cancer
8
cancer patients
8
standard therapy
8
hyperthermia immunotherapy
8
[immunotherapy hyperthermia
4
hyperthermia advanced
4
patients standard
4
therapy refused]
4

Similar Publications

Reservoir computing (RC) is a powerful machine learning algorithm for information processing. Despite numerous optical implementations, its speed and scalability remain limited by the need to establish recurrent connections and achieve efficient optical nonlinearities. This work proposes a streamlined photonic RC design based on a new paradigm, called next-generation RC, which overcomes these limitations.

View Article and Find Full Text PDF

Pattern memory cannot be completely and truly realized in deep neural networks.

Sci Rep

December 2024

School of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, 214122, China.

The unknown boundary issue, between superior computational capability of deep neural networks (DNNs) and human cognitive ability, has becoming crucial and foundational theoretical problem in AI evolution. Undoubtedly, DNN-empowered AI capability is increasingly surpassing human intelligence in handling general intelligent tasks. However, the absence of DNN's interpretability and recurrent erratic behavior remain incontrovertible facts.

View Article and Find Full Text PDF

the evolution of axillary management in breast cancer has witnessed significant changes in recent decades, leading to an overall reduction in surgical interventions. There have been notable shifts in practice, aiming to minimize morbidity while maintaining oncologic outcomes and accurate staging for newly diagnosed breast cancer patients. These advancements have been facilitated by the improved efficacy of adjuvant therapies.

View Article and Find Full Text PDF

Survival outcomes and contributing factors in oral squamous cell carcinoma patients in Khuzestan province, southwest of Iran.

Front Oncol

December 2024

Social Determinants of Health Research Center, Department of Public Health, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran.

Background: Oral squamous cell carcinoma (OSCC) is the most frequent oral cancer worldwide. Despite advances in OSCC treatment, the mortality rate has not decreased in recent years. Therefore, the aim of this investigation was to assess the survival rate as a factor reflecting the quality aspects of care and background parameters that influence survival in patients with OSCC.

View Article and Find Full Text PDF

A 63-year-old woman undergoing peritoneal dialysis (PD) presented to our hospital with abdominal pain, diarrhea, and cloudy PD effluent. An elevated white blood cell count in the PD effluent led to a diagnosis of PD-associated peritonitis. She was subsequently started on intraperitoneal cefazolin and ceftazidime, after which her condition improved rapidly.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!